Submission Details
| 510(k) Number | K250684 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 06, 2025 |
| Decision Date | July 02, 2025 |
| Days to Decision | 118 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K250684 is an FDA 510(k) clearance for the OPUSWAVE Dual Sensor Imaging System, a System, Imaging, Optical Coherence Tomography (oct) (Class II — Special Controls, product code NQQ), submitted by Terumo Cardiovascular Systems Thi Plant (Ann Arbor, US). The FDA issued a Cleared decision on July 2, 2025, 118 days after receiving the submission on March 6, 2025. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 892.1560.
| 510(k) Number | K250684 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 06, 2025 |
| Decision Date | July 02, 2025 |
| Days to Decision | 118 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | NQQ — System, Imaging, Optical Coherence Tomography (oct) |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 892.1560 |
| Definition | This Device Uses Back-reflected Light To Create Two-dimensional Images Versus Back-reflected Sound Waves As Are Used In Ultrasound Imaging. |